SCOPUS 정보 검색 플랫폼

Volumn 50, Issue 2, 2002, Pages 151-154

A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: A gynecologic oncology group study

(7) Plaxe, Steven C a Blessing, John A b Olt, George c Husseinzadah, Nader d Lentz, Samuel S e DeGeest, Koen f Valea, Fidel A g

a UCSD MEDICAL CENTER (United States)

b ROSWELL PARK CANCER INSTITUTE (United States)

c PENN STATE MILTON S HERSHEY MEDICAL CENTER (United States)

d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE (United States)

e WAKE FOREST SCHOOL OF MEDICINE (United States)

f RUSH MEDICAL COLLEGE (United States)

g STONY BROOK UNIVERSITY (United States)

Author keywords

Cervical cancer; Pyrazoloacridine; PZA

Indexed keywords

2 (2 DIMETHYLAMINOETHYL) 9 METHOXY 5 NITROPYRAZOLO[3,4,5 KL]ACRIDINE;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GYNECOLOGY; HUMAN; NEUTROPENIA; ONCOLOGY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT DISEASE; REDUCTION; SQUAMOUS CELL CARCINOMA; TOXICITY; UTERINE CERVIX CARCINOMA;

ACRIDINES; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INTERCALATING AGENTS; MIDDLE AGED; NEUTROPENIA; NUCLEIC ACID SYNTHESIS INHIBITORS; PYRAZOLES; REMISSION INDUCTION; SALVAGE THERAPY; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VOMITING;

EID: 0036353160 PISSN: 03445704 EISSN: None Source Type: Journal
DOI: 10.1007/s00280-002-0470-2 Document Type: Article

Times cited : (9)

References (18)

1
- 0031948557
- Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II
- (1998) Clin Cancer Res , vol.4 , pp. 683-691
- Adjei, A.A.¹ Charron, M.² Rowinsky, E.K.³ Svingen, P.A.⁴ Miller, J.⁵ Reid, J.M.⁶ Leopold, J.⁷ Ames, M.M.⁸ Kaufmann, S.H.⁹

2
- 0032826587
- Current status of pyrazoloacridine as an anticancer agent
- (1999) Invest New Drugs , vol.17 , pp. 42-48
- Adjei, A.A.¹

3
- 0036534291
- Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: A Gynecologic Oncology Group study
- (2002) J Clin Oncol , vol.20 , pp. 1832-1837
- Bloss, J.D.¹ Blessing, J.A.² Behrens, B.C.³ Mannel, R.S.⁴ Rader, J.S.⁵ Sood, A.K.⁶ Markman, M.⁷ Benda, J.⁸

4
- 0033890184
- Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinoma
- (2000) Invest New Drugs , vol.18 , pp. 247-251
- Dodd, P.M.¹ McCaHrey, J.A.² Mazumdar, M.³ Icasaino, E.⁴ Higgins, G.⁵ Herr, H.⁶ Bajorin, D.⁷

5
- 0029583393
- Phase I clinical trial of pyrazoloacridine (PD115934)
- (1995) Clin Cancer Res , vol.1 , pp. 1487-1493
- LoRusso, P.¹ Foster, B.J.² Poplin, E.³ McCormick, J.⁴ Kraut, M.⁵ Flaherty, L.⁶ Heilbrun, L.K.⁷ Valdivieso, M.⁸ Baker, L.⁹

6
- 0002989449
- A randomized phase III study of cisplatin versus cisplatin plus paclitaxel in stage IVb, recurrent or persistent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
- (2001) Proc Am Soc Clin Oncol , vol.20 , pp. 801
- Moore, D.H.¹ McQuellon, R.P.² Blessing, J.A.³ Thaler, H.⁴ Benda, J.⁵ Miller, D.S.⁶ Olt, G.⁷ King, S.⁸ Boggess, J.⁹ Roccereto, T.¹⁰

7
- 0031023552
- Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
- (1997) J Clin Oncol , vol.15 , pp. 165-171
- Omura, G.A.¹ Blessing, J.A.² Vacarello, L.³ Berman, M.L.⁴ Clarke-Pearson, D.L.⁵ Mutch, D.⁶ Anderson, B.⁷

8
- 0022624359
- Radiation alone in treatment of carcinoma of the uterine cervix: A 20 year experience
- (1986) Gynecol Oncol , vol.23 , pp. 127-140
- Perez, C.A.¹ Camel, M.H.² Kuske, R.R.³ Kao, M.S.⁴ Galakatos, A.⁵ Hederman, M.A.⁶ Powers, W.E.⁷

9
- 0036141074
- Phase II trial of pyrazoloacridine in recurrent platinum sensitive ovarian cancer: A Gynecologic Oncology Group study
- (2002) Gynecol Oncol , vol.84 , pp. 32-35
- Plaxe, S.C.¹ Blessing, J.A.² Bookman, M.A.³ Creasman, W.T.⁴

10
- 0036166751
- Phase II trial of pyrazoloacridine in patients with persistent or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
- (2002) Gynecol Oncol , vol.84 , pp. 241-244
- Plaxe, S.C.¹ Blessing, J.A.² Husseinzadeh, N.³ Webster, K.D.⁴ Rader, J.S.⁵ Dunton, C.J.⁶

11
- 0029045628
- Phase and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent on single-dosing and multiple-dosing schedules
- (1995) J Clin Oncol , vol.13 , pp. 1975-1984
- Rowinsky, E.K.¹ Noe, D.A.² Grochow, L.B.³ Sartorious, S.E.⁴ Bowling, M.K.⁵ Chen, T.L.⁶ Lubejko, B.G.⁷ Kaufmann, S.H.⁸ Donnhower, R.C.⁹

12
- 0023218399
- Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro
- (1987) Cancer Res , vol.47 , pp. 4299-4304
- Sebolt, J.S.¹ Scavone, S.V.² Pinter, C.D.³ Hamelehle, K.L.⁴ Von Hoff, D.D.⁵ Jackson, R.C.⁶

13
- 0024790114
- A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
- (1987) J Clin Oncol , vol.7 , pp. 1892-1895
- Stehman, F.B.¹ Blessing, J.A.² McGehee, R.³ Barrett, R.J.⁴

14
- 0024450677
- Phase II study of ifosfamide and mesna in patients with previously treated carcinoma of the cervix: A Gynecologic Oncology Group study
- (1989) Invest New Drugs , vol.7 , pp. 341-343
- Sutton, G.P.¹ Blessing, J.A.² Adcock, L.³ Webster, K.D.⁴ DeEulis, T.⁵

15
- 0019408691
- Cisplatinum in the treatment of advanced or recurrent squamous carcinoma of the cervix. A phase II study of the Gynecologic Oncology Group
- (1981) Cancer , vol.48 , pp. 899-903
- Thigpen, T.¹ Shingleton, H.² Homesley, H.³ Lagasse, L.⁴ Blessing, J.⁵

16
- 0033894907
- Phase II trial of pyrazoloacridine in patients wit cisplatin-refractory germ cell tumors
- (2000) Invest New Drugs , vol.18 , pp. 265-267
- Vuky, J.¹ McCaffrey, J.² Ginsberg, M.³ Mariani, T.⁴ Bajorin, D.F.⁵ Bosl, G.J.⁶ Motzer, R.J.⁷

17
- 0030908801
- Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma
- (1997) Cancer Chemother Pharmacol , vol.40 , pp. 225-227
- Zalupski, M.M.¹ Philip, P.A.² LoRusso, P.³ Shields, A.F.⁴

18
- 0031824186
- Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma
- (1998) Invest New Drugs , vol.16 , pp. 93-96
- Zalupski, M.M.¹ Shields, A.F.² Philip, P.A.³ Kraut, M.⁴ LoRusso, P.⁵ Heilbrun, L.K.⁶ Vaitkevicius, V.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.